Open Invitation Issued to Corporate and Government Organizations to Mitigate Pandemic
CAMPBELL, Calif.–(BUSINESS WIRE)–March 30, 2020–
Saama Technologies, Inc. (“Saama”), the #1 AI medical analytics platform firm, introduced at present that it’ll contribute its AI-powered Life Science Analytics Cloud (LSAC) know-how platform to ascertain the FinishPandemic National Data Consortium. The single objective is to combine information from all ongoing and future medical research to dramatically speed up evaluation on COVID-19 and SARS-CoV-2 analysis to be able to scale back the time to discover a remedy by as much as 50%. Saama’s distinctive platform will enable researchers to dynamically visualize, analyze, and interrogate information throughout all obtainable packages.
“As a life sciences software company we are humbled to work with and provide technology to the brilliant professionals who tirelessly toil to solve this worldwide crisis. Working in clinical analytics, we truly understand the value derived from integrating research data and applying machine learning and predictive analytics technologies to enable better science,” stated Suresh Katta, Founder and CEO of Saama Technologies. “We challenge all scientific personnel and technology companies to join the EndPandemic National Data Consortium to work together during this crisis to pool relevant data to find treatments – and hopefully a cure – for SARS-CoV-2.”
“We won’t find rapid solutions for the SARS-CoV-2 pandemic with our data remaining so fragmented,” stated David Shulkin, M.D., the Ninth Secretary, US Department of Veterans Affairs. “In order to adequately address this pandemic, we must share data from clinical studies across the research, healthcare, and pharma communities. By having comprehensive datasets and deep data analytics we will have the opportunity to make great progress.”
Companies serious about becoming a member of the FinishPandemic National Data Consortium to collaborate and speed up options to the pandemic ought to contact Saama at [email protected] or 888.970.3550.
Life Science Analytics Cloud (LSAC) is the main AI-powered medical analytics platform that seamlessly integrates, curates, and animates medical trial information, delivering extra actionable insights for quicker determination making.
About Saama Technologies, Inc.
Saama is the #1 AI medical analytics platform firm, enabling the life sciences trade to conduct quicker and safer medical improvement and regulatory packages. Today, over 50 biotech firms use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on greater than 1,500 research, together with most of the high 20 pharmaceutical firms. LSAC’s wealthy purposes facilitate an unprecedented, authoritative oversight of complete medical analysis information, enabling firms to file New Drug Applications (NDAs) extra effectively and produce medicine to market quicker. Discover extra at www.saama.com and comply with Saama @SaamaTechInc.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20200330005171/en/